Search Results - "Chelysheva, E. Y."

P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY by Khadadah, F., Turkina, A. G., Lomaia, E., Morozova, E. V., Shukhov, O. A., Petrova, A., Chitanava, T., Vlasova, J. J., Kuzmina, E., Nemchenko, I., Chelysheva, E. Y., Bykova, A., Gurianova, M., Xenocostas, A., Busque, L., Jamani, K., Cerquozzi, S., Kuruvilla, P., Kaedbey, R., Leber, B., Assouline, S., Kim, D. D. H.

Get full text

Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia by Chelysheva, Ekaterina Yu, Petrova, Anna N., Shukhov, Oleg A., Bykova, Anastasiia V., Nemchenko, Irina S., Gurianova, Margarita A., Tsyba, Nikolay N., Turkina, Anna G.

“…Background. Withdrawal syndrome (WS) a musculoskeletal pain after discontinuation of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukemia…”
Get full text

Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review by Gurianova, M A, Chelysheva, E Y, Shukhov, O A, Turkina, A G

“…Therapy with tyrosine kinase inhibitors (TKI) allows to achieve a deep molecular response in 6070% of patients with chronic myeloid leukemia (CML). According…”
Get full text

Cytogenetic response as a marker of efficacy of chronic myeloid leukemia therapy with a BCR-ABL thyrosine kinase inhibitor glivek by Turkina, A G, Kruglov, S S, Druzhkova, G A, Domracheva, E V, Zakharova, A V, Vinogradova, O Iu, Sysoeva, E P, Diachenko, L V, Chelysheva, E Iu, Zakharova, E S, Abakumov, E M, Kolosheĭnova, T I, Kolosova, L Iu, Ivanova, T V, Zhuravlev, V S, Nemchenko, I S, Zingerman, B V, Kurova, E S, Triputen', N Z, Loriia, S S, Kovaleva, L G, Khoroshko, N D

“…Clinical practice with the drug glivek (imatinibe mesilate, ST1571) blocking activity of oncoprotein p210 shows that a cytogenetic response can be reached in…”
Get more information